Meeks places hold on $2.8B US bomb sale to Israel

Key points

• Gregory Meeks, the top Democrat on the House Foreign Affairs Committee, announced an informal hold on the $2.8 billion arms package on Tuesday.
• The proposed sale includes 20,000 MK-84 bombs, 20,000 BLU-117 bombs, and 20,000 I-2000 penetrator warheads.
• Meeks stated that the Trump administration failed to provide sufficient assurances regarding the lawful use of the weapons and protections for civilians.
• The sale is funded through the Foreign Military Financing program, which uses appropriated US funds for eligible allies.
• Blocking the sale entirely would require a veto-proof joint resolution of disapproval in both chambers of Congress, a high bar that has not been met previously.
• The Trump administration has already expedited over $12 billion in arms for Israel since taking office, including a previous $3 billion package in 2025 that bypassed normal review.

Background

This development follows a series of earlier reports in September 2026 regarding the same $2.8 billion package. Previous coverage noted that the deal had been informally briefed to Congress but was not yet final. The current hold by Meeks represents a formal procedural step in the 'tiered review' process, where top lawmakers can delay major weapons transfers before formal congressional notification. This follows a pattern of shifting US policy on heavy munitions, including a pause by the Biden administration in 2024 and subsequent expedited sales by the Trump administration.

How outlets are covering it

Outlets differ in their framing of the political and legal implications. The Guardian emphasizes the procedural leverage of Meeks's hold within the 'tiered review' custom and notes the administration's previous use of national security emergencies to bypass oversight. Fox News highlights the bipartisan opposition from Senators Bernie Sanders and Chris Van Hollen, framing the sale as a contentious use of taxpayer funds. The New York Times focuses on the strategic rationale, suggesting the large volume of bombs may be an effort to stock Israel's arsenal before potential political shifts make such shipments impossible. All sources agree on the core facts: the $2.8 billion value, the 40,000 bomb count, and the specific types of munitions involved.

Why it matters

The hold signals a potential shift in congressional oversight of US arms sales to Israel, moving from informal support to active procedural resistance. It underscores the tension between executive branch urgency and legislative scrutiny regarding the use of US weapons in conflict zones. If the sale proceeds despite the hold, it may set a precedent for bypassing informal congressional sign-offs in future major arms transfers.

What to watch

The State Department has not yet responded to requests for comment regarding the hold. The administration may attempt to bypass the informal review by declaring a national security emergency, as was done in 2025. Alternatively, the sale may proceed to formal congressional notification, where it could face a joint resolution of disapproval, though such a measure requires a two-thirds majority in both chambers. Meeks's hold may also prompt further debate on the Leahy laws and international humanitarian law compliance in US foreign military financing.